Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FD675
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,043
Award facts
- Contract value 100% obligated
- $12,042.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,042.67 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulation. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 30, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor primarily supporting the Defense Logistics Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Cosentyx, a specialty immunosuppressant medication used in treating inflammatory conditions, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for Department of Defense and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FD675?
SPE2DR26FD675 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FD675 worth?
The government has obligated $12,043 on SPE2DR26FD675.
Is contract SPE2DR26FD675 an order under another contract?
Yes. SPE2DR26FD675 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD675 competed?
The extent of competition for SPE2DR26FD675 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award